| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $38.54B | +5.8% |
| Cost of Revenue | $27.60B | +24.4% |
| Gross Profit | $10.94B | -23.3% |
| R&D Expense | $400.0M | +0.0% |
| SG&A Expense | $7.17B | -3.6% |
| Operating Income | $3.55B | -44.1% |
| Interest Expense | $599.0M | +17.9% |
| Pre-tax Income | $3.01B | -51.9% |
| Income Tax | $782.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $3.90B | +0.7% |
| Inventory | $4.42B | +15.5% |
| Current Assets | $12.95B | -2.2% |
| Total Assets | $71.49B | +4.4% |
| Current Liabilities | $21.86B | +11.8% |
| Long-term Debt | $17.22B | +9.9% |
| Total Liabilities | $45.60B | +9.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.51B | -8.1% |
| Capital Expenditures | $1.28B | -7.8% |
| Investing Cash Flow | -$1.20B | -327.4% |
| Financing Cash Flow | -$2.76B | +52.3% |
| Free Cash Flow | $3.23B | -8.2% |
| -46.8% |
| Net Income | $2.45B | -46.8% |
| EPS (Basic) | $1.89 | -45.1% |
| EPS (Diluted) | $1.89 | -44.7% |
| Stockholders' Equity |
| $25.84B |
| -4.1% |